Timing considerations for hypospadias surgery

Posted on Tuesday, October 21st, 2014 at 11:40 am    

Hypospadias is a birth defect where the urethral opening is abnormally placed. Some minor cases do not interfere with functionality, but more severe cases may require surgery. Timing of the surgery is a major consideration for corrective treatments.

Medical literatures vary on their opinion as to the proper timing for hypospadias repair. The American Academy of Pediatrics suggested that babies with hypospadias should undergo corrective treatments between 6 months to 1 year old. Others suggested that surgery should be done as early as 4 months after birth, given that the penis a suitable length for repair in male patients. However, those with more complicated cases may need to wait for several years before undergoing surgery. Other factors that medical experts will need to consider in regards to timing is an evaluation of underlying conditions linked to the hypospadias and if hormonal stimulation is first needed.

Treating hypospadias can become expensive, especially if the patient will need to undergo series of surgeries to correct the defect. However, you may be entitled to treatment funds if you think that your loved one’s hypospadias is linked to fetal exposure of Topamax during pregnancy. Find out how the Williams Kherkher legal team may possibly advocate for you today by calling (800) 220-9341.

The progression of ovarian cancer

Posted on Tuesday, October 21st, 2014 at 11:22 am    

In the U.S., cancer of the ovaries is associated with thousands of cancer deaths among women. The National Cancer Institute even estimated that a woman’s lifetime risk of dying from this type of invasive disease is 1 out of 100.

Treatment for ovarian cancer largely depends on its severity. To measure how far the cancer has developed and spread, doctors follow a simple staging system with four categories:

  • Stage 1 – The cancer can be found inside or on the surface of one or both ovaries
  • Stage 2 – The cancer has spread outside the ovaries, affecting the organs surrounded by the hip bones
  • Stage 3 – The cancer can be found on the areas outside the pelvic bones and within the abdominal cavity
  • Stage 4 – The cancer has spread to other distant organs of the body, including the heart, the lungs, and the liver

Unfortunately, thousands of cases of ovarian cancer have been associated with the use of female sanitary products containing talcum powder. If you believe your situation is a result of talcum powder use, a lawyer at Williams Kherkher can help you decide whether to pursue legal action against the drug manufacturer involved. Call us at 800-220-9341 today.

Juneau defends his actions as BP asks for his removal

Posted on Monday, October 20th, 2014 at 10:06 am    

Court-appointed Deepwater Horizon oil spill claims administrator Patrick Juneau said in a filing with the United States Supreme Court that he has process and granted claims awards according to the settlement guidelines, despite BP’s allegations that he misinterpreted the settlement, The Times-Picayune reported on October 7.

The filing was in response to BP’s September request to a federal judge to have Juneau removed as claims administrator, alleging that Juneau did not report a conflict of interest. In fact, BP wants the settlement to be thrown out entirely, as the company believes many people and businesses were given awards even though their losses were not related to the oil spill.

The explosion of the Deepwater Horizon led to the oil spill in the Gulf of Mexico in 2010, affecting many businessmen and residents living and working nearby. If you are among those affected by the oil spill, get in touch with our attorneys at the Williams Kherkher by dialing 800-220-9341 today.

Risperdal-induced priapism may lead to sexual dysfunction

Posted on Friday, October 17th, 2014 at 3:00 pm    

In 2009, The Primary Care Companion to The Journal of Clinical Psychiatry presented a case study involving a 31-year old African-American man who suffered 10 days of priapism, or prolonged and painful penile erection without sexual stimulation, after taking the atypical antipsychotic drug Risperdal.

According to the case report, 15% to 26% of cases of priapism have been associated with the use of antipsychotic drugs, including Risperdal. Antipsychotics are well-recognized to have direct effects on the mechanism that preserves the flaccidity of the penis. If left untreated, Risperdal-induced priapism may lead to other male sexual dysfunctions, such as penile disfigurement and failure to get and maintain an erection (erectile dysfunction).

Unfortunately, Risperdal has also been associated with many different, some even life-threatening medical complications, such as neuroleptic malignant syndrome and heart attacks. If taking Risperdal has compromised you or your loved one’s health, consider filing a legal claim by speaking with our team at Williams Kherkher. You may reach us at (800) 220-9341.

Belviq may cause depression and other side effects

Posted on Friday, October 17th, 2014 at 2:51 pm    

In 2012, the U.S. Food and Drug Administration (FDA) approved Belviq, a pill that promises weight loss with proper diet and increased physical activity. It is classified as a serotonergic drug, which means it has a direct effect on the body’s level of serotonin, a brain chemical known to curb appetite.

However, clinical studies suggest persistent use of serotogenic drugs can actually be pro-depressant. In fact, pre-marketing trials of the drug suggest the drug may cause the emergence and worsening of depression and other psychiatric disorders such as suicidal thoughts and behavior, euphoria, dissociation, and hallucination. Cognitive effects, such as memory loss, loss of focus, and confusion have also been associated with its use.

If using Belviq has caused you more harm than good, let our legal team at Williams Kherkher help you pursue the justice and compensation you believe you deserve. Call us at (800) 220-9341 to seek help in possibly filing a lawsuit.

Viagra ad uses female concerns to sell product

Posted on Thursday, October 16th, 2014 at 1:09 pm    

The new ad for Viagra, a drug used to treat erectile dysfunction, features a woman speaking directly to the male audience about impotence and its negative aspects, The Desert Sun reported on October 4.

This new strategy is being harnessed by Pfizer, Inc., Viagra’s manufacturer, as a means to generate sales for the drug, which is its No. 6 best seller. Its patent has already expired in Europe over a year ago, and will also be up in the U.S. in three years. Cheaper, generic versions have contributed to its sale losses in Europe.

In 2013, sales of Viagra in Europe plummeted by 8% to a mere $1.9 billion, and the drug is expecting some serious competition from generic brands when its patent expires in the U.S., as these generic alternatives will cost a mere $35 a pill.

New research about the drug Viagra has showed that there might be a link between the use of the drug that treats erectile dysfunction and the development of melanoma, a type of skin cancer. If you suspect that Viagra contributed to your development of melanoma, call our attorneys at Williams Kherkher by dialing 800-220-9341 and discuss your options for pursuing financial compensation.

Nearly 7,000 cases filed against J&J for DePuy hip implant

Posted on Thursday, October 16th, 2014 at 12:52 pm    

A whopping 6,849 lawsuits have already been filed in Texas against the pharmaceutical manufacturer Johnson & Johnson in regards to its notoriously dangerous DePuy hip implant product, the Southeast Texas Record reported on October 7.

The lawsuits alleged that Johnson & Johnson subsidiary DePuy Orthopaedics Inc., the manufacturer of the Pinnacle hip implant, did not warn consumers of the dangers that using these hip implants can bring. The defect, the plaintiffs claimed, can cause metal to seep into the patient’s bloodstream, resulting in chromium and cobalt buildup. This buildup can create substantial and long-lasting health complications, including metallosis, continuous pain, and more.

The first trial concerning the Pinnacle implant began on September 3 in the Northern District of Texas (Herlihy-Paoli v. DePuy Orthopaedics Inc.). The plaintiff in that case was a 58-year-old woman from Montana who acquired a metal-on-metal hip implant for her right hip in September 2006 and another for her left hip in April 2007. In 2010, she had the implants both removed via surgery and discovered that her left hip had turned black with metallosis.

Hip implants are designed to give aid to people suffering from hip pain. Unfortunately, hip implant products like DePuy may cause far more harm than good in consumers. If you have suffered negative effects from a DePuy hip implant, call the legal team at Williams Kherkher today at (800) 220-9341 to learn about your options for pursuing financial restitution.

When to seek medical help while using Xarelto

Posted on Wednesday, October 15th, 2014 at 3:12 pm    

Individuals who are taking the anticoagulant medication Xarelto to treat blood clots like deep vein thrombosis (DVT) should immediately seek medical help if they experience the following symptoms:

  • Any unusual bleeding like frequent nosebleed or bleeding gums
  • Unusual coloration of stool or urine
  • Swollen and painful wounds
  • Weakness, nausea, and headaches
  • Coughing or vomiting blood
  • Unusually heavy menstruation or bleeding in the vaginal area

These symptoms could be the first warning signs of a serious problem, and you are advised to seek medical attention immediately.

If you think you have been injured by the potentially dangerous drug, the legal team at Williams Kherkher may represent you. Consult your situation with us today by dialing (800) 220-9341 to find out how we may possibly help you recover your loss.

Widow files wrongful death claim against Benicar manufacturer

Posted on Wednesday, October 15th, 2014 at 2:57 pm    

A widow recently filed a wrongful death claim in New Jersey after her husband allegedly died as a result of ingesting the blood pressure medicine Benicar, an article on Market Watch stated October 1.

According to reports, William Kuznicki was hospitalized when he developed intestinal distress and severe diarrhea after taking Benicar in 2012. Kuznicki’s condition continued to deteriorate, and he died in February of last year. The wrongful death claim filed by Kuznicki’s widow alleges that drug manufacturers did not put a warning box detailing the possible intestinal side effects linked to Benicar use, even though there is speculation that the company was aware of this problem following an evaluation performed by the Mayo clinic in 2012. Ms. Kuznicki is one of several others filing similar suits in New Jersey alone.

The attorneys of Williams Kherkher believe in fighting for those who were mislead or injured by big pharmaceutical companies. If you’ve had a negative experience as a result of taking Benicar for treating high blood pressure, let our lawyers evaluate your case today to see if you may qualify. Call (800) 220-9341 to find out how we may advocate for you.

What you need to know about Qysmia and depression

Posted on Thursday, October 9th, 2014 at 1:22 pm    

Qysmia is a prescription drug recently approved by the U.S. Food and Drug Administration for weight management. Over the years, however, several adverse effects have been reported to be associated with this medication, including depression.

The medication is an extended release of two active drugs: phentermine and topiramate. Phentermine works by amplifying brain chemical norepinephrine to suppress appetite. On the other hand, anticonvulsant and antimigraine drug topiramate induces an increased level of satiety among Qysmia users, making them feel satisfied and full. However, several clinical trials of topiramate have suggested the drug may increase the risk of suicidal ideation and may worsen depression among individuals taking it.

If taking Qysmia has caused you to suffer from depression, our product liability attorneys at Williams Kherkher are ready to help you pursue the compensation you believe you are owed. Call us at (800) 220-9341 to explore the possibility of holding the manufacturer of the drug legally accountable for all the damages you have incurred.

1 2 3 37

Williams Kherkher | 8441 Gulf Fwy #600 | Houston, TX 77017 | Phone: (713) 230-2200 | Toll Free: (800) 220-9341 | Directions